Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Use of PKM-MULTI program for fitting discontinuous absorption profiles using a microcomputer.

N Kaniwa, N Aoyagi, H Ogata

    Journal of Pharmacobio-Dynamics
    |December 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Active oxygen species generation and cellular damage by additives of parenteral preparations: selenium and sulfhydryl compounds.

    Nutrition (Burbank, Los Angeles County, Calif.)·1999
    Same author

    Functional expression of costimulatory molecule CD86 on epithelial cells in the inflamed colonic mucosa.

    Gastroenterology·1999
    Same author

    Kinetic factors determining wheelchair propulsion in marathon racers with paraplegia.

    Spinal cord·1999
    Same author

    Combination therapy for advanced breast cancer: cyclophosphamide, doxorubicin, UFT, and tamoxifen.

    Oncology (Williston Park, N.Y.)·1999
    Same author

    Subjective evaluations and objective measurements of the ischial-ramal containment prosthesis.

    Journal of UOEH·1999
    Same author

    [A study on the efficacy of combination chemoendocrine therapy consisting of cyclophosphamide, adriamycin, UFT, and tamoxifen for advanced or recurrent breast cancer].

    Gan to kagaku ryoho. Cancer & chemotherapy·1999

    This study introduces PKM-MULTI, a program for pharmacokinetic modeling with discontinuous absorption. It accurately fits data, showing better validity than continuous absorption models for nalidixic acid plasma data.

    Area of Science:

    • Pharmacokinetics
    • Computational Biology
    • Pharmacometrics

    Background:

    • Pharmacokinetic modeling is crucial for drug development and understanding drug behavior in the body.
    • Accurate estimation of pharmacokinetic parameters requires robust computational tools.
    • Discontinuous absorption models offer a more realistic representation for certain drug administration routes.

    Purpose of the Study:

    • To develop and validate a new computational program, PKM-MULTI, for pharmacokinetic modeling.
    • To assess the performance of PKM-MULTI by comparing its results with existing methods.
    • To evaluate the utility of discontinuous absorption models for real-world pharmacokinetic data.

    Main Methods:

    • Developed pharmacokinetic models with discontinuous absorption in BASIC.

    Related Experiment Videos

  • Integrated these models with the MULTI nonlinear least squares program.
  • Designated the integrated program as PKM-MULTI.
  • Fitted existing data sets and plasma data of nalidixic acid using PKM-MULTI.

    • Main Results:

    • PKM-MULTI successfully fitted previously analyzed data sets.
    • Estimates obtained using PKM-MULTI showed close agreement with results from HFCM, FITSI2, and NONLIN.
    • Application to nalidixic acid plasma data indicated the superiority of the discontinuous absorption model.

    Conclusions:

    • PKM-MULTI is a reliable tool for pharmacokinetic modeling, particularly for discontinuous absorption.
    • The discontinuous absorption model provides a more valid pharmacokinetic representation for nalidixic acid compared to continuous absorption models.